A re-evaluation of imaging criteria to assess aggressive masticator space tumors

Purpose To evaluate the correlation between the gross imaging evidence of an aggressive masticator space (MS) tumor and the presence of such a MS malignancy. Materials and Methods Thirty patients were identified retrospectively who had a malignancy that either arose in or metastasized to the MS, had...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Head & neck 1997-07, Vol.19 (4), p.335-341
Hauptverfasser: Som, Peter M., Curtin, Hugh D., Silvers, Adam R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose To evaluate the correlation between the gross imaging evidence of an aggressive masticator space (MS) tumor and the presence of such a MS malignancy. Materials and Methods Thirty patients were identified retrospectively who had a malignancy that either arose in or metastasized to the MS, had pathologic verification of the diagnosis, and had magnetic resonance (MR) and/or computed tomographic (CT) images. Specifically evaluated was the presence or absence of gross imaging evidence of mandibular erosion and the integrity of the medial MS fascia as evaluated by a smooth margin between this fascia and the parapharyngeal space fat. Results Of the 30 tumors, 28 were high‐grade malignancies and 2 were histiocytoses. Of these, 5 had mandibular erosion and violation of the MS fascia, 19 had bone erosion with an intact fascia, 4 had neither bone erosion nor fascial violation (3 of these patients were under the age of 20 years), and 2 had fascial violation with no bone erosion. Conclusions In 76.7% of patients with a malignancy arising in the MS, on imaging the medial MS fascia was grossly intact. There were 4 patients with MS malignancy and neither violation of the medial MS fascia nor mandibular bone erosion. Thus, these imaging findings may not be good criteria to evaluate the presence of a high‐grade MS malignancy, especially if the patient is under the age of 20 years, in which age group MS sarcomas are more likely to arise. © 1997 John Wiley & Sons, Inc. Head Neck 19: 335–341, 1997.
ISSN:1043-3074
1097-0347
DOI:10.1002/(SICI)1097-0347(199707)19:4<335::AID-HED12>3.0.CO;2-8